| The Debiopharm Life Sciences Award / Switzerland |
|
The 2010 Debiopharm Life Sciences Award will be granted on September 2nd at 17h00, during the Annual EPFL Life Science Symposium to be held from September 2 to 4, 2010 in Lausanne. The 2010 Award will honour a European investigator below the age of 45 who has made outstanding contribution in the area of new drug delivery or pharmaceutical technology approaches. The deadline for application was May 10th, 2010 (see Application details). The Debiopharm Life Sciences Award is a tribute of Debiopharm Group to innovation as the key engine to medical progress, and it aims at motivating young innovative European researchers in the field of life sciences. It consists of a total amount of 100'000 Swiss Francs. One half of this amount is a personal reward and the other half supports the recipient's research. The research of potential candidates must show therapeutic and industrial potential in life sciences; novelty and originality; as well as importance and significance in connection with targeted therapeutic fields. Debiopharm Group thanks the EPFL School of Life Sciences for its continuous support in the organisation of this Award. Nominees:
2010
2009
Dr Lluis Quintana-Murci, UP Human Evolutionary Genetics, Institut Pasteur, France The Debiopharm Life Sciences Award goes to Dr Lluis Quintana-Murci for his novel and original research on the human evolutionary genetics of infection 2008
Dr Manel Esteller, Epigenetics Laboratory at the National Cancer Center (CNIO) Madrid, Spain Debiopharm Life Sciences Award in Epigenetic Oncology goes to Dr Manel Esteller
2007
Dr Zoltan Nusser, Hungarian Academy of Sciences, Budapest, Hungary Debiopharm Life Sciences Award in Neurosciences Goes to Nusser
2006
Dr Eduard Batlle, Institut de Recerca Biomèdica of Barcelona, Spain. Debiopharm and EPFL honour Dr Eduard Batlle with the "Debiopharm Life Sciences Award"
|